| 003589 (2006) |
Michael P. Hill [Royaume-Uni] ; Paula Ravenscroft [Royaume-Uni] ; Steven G. Mcguire [Royaume-Uni] ; Jonathan M. Brotchie [Royaume-Uni, Canada] ; Alan R. Crossman [Royaume-Uni] ; Catherine Rochat [France] ; Mark J. Millan [France] | Antiparkinsonian effects of the novel D3/D2 dopamine receptor agonist, S32504, in MPTP‐lesioned marmosets: Mediation by D2, not D3, dopamine receptors |
| 005D97 (1993) |
Baltazar Gomez-Mancilla [Canada, Suisse] ; René Boucher [Canada, Suisse] ; Céline Gagnon [Canada, Suisse] ; Thérèse Di Paolo [Canada, Suisse] ; Rudolf Markstein [Canada, Suisse] ; Bédard [Canada, Suisse] | Effect of adding the D1 agonist CY 208–243 to chronic bromocriptine treatment. I: Evaluation of motor parameters in relation to striatal catecholamine content and dopamine receptors |
| 005E85 (1993) |
B. Gomez-Mancilla [Canada] ; R. Boucher ; C. Gagnon ; T. Di Paolo ; R. Markstein ; P. J. Bedard | Effect of adding the D1 agonist CY 208-243 to chronic bromocriptine treatment. I: Evaluation of motor parameters in relation to striatal catecholamine content and dopamine receptors |
| 000618 (2014) |
Julia Kraemmer [Autriche] ; Gabor G. Kovacs ; Laura Perju-Dumbrava ; Susanne Pirker ; Tatiana Traub-Weidinger ; Walter Pirker | Correlation of striatal dopamine transporter imaging with post mortem substantia nigra cell counts. |
| 000769 (2013) |
Morvarid Karimi [États-Unis] ; Stephen M. Moerlein [États-Unis] ; Tom O. Videen [États-Unis] ; Y. Su [États-Unis] ; Hubert P. Flores [États-Unis] ; Joel S. Perlmutter [États-Unis] | Striatal dopamine D1-like receptor binding is unchanged in primary focal dystonia |
| 001244 (2011) |
Vibeke Guldbrand Rasmussen [Danemark] ; Karen Stergaard ; Erik Dupont ; Steen Hvitfeldt Poulsen | The risk of valvular regurgitation in patients with Parkinson's disease treated with dopamine receptor agonists. |
| 001313 (2011) |
Vibeke Guldbrand Rasmussen [Danemark] ; Karen Stergaard [Danemark] ; Erik Dupont [Danemark] ; Steen Hvitfeldt Poulsen [Danemark] | The risk of valvular regurgitation in patients with Parkinson's disease treated with dopamine receptor agonists |
| 001645 (2011) |
Marios Politis [Royaume-Uni] ; Wolfgang H. Oertel [Allemagne] ; Kit Wu [Royaume-Uni] ; Niall P. Quinn [Royaume-Uni] ; Oliver Pogarell [Allemagne] ; David J. Brooks [Royaume-Uni] ; Anders Bjorklund [Suède] ; Olle Lindvall [Suède] ; Paola Piccini [Royaume-Uni] | Graft‐induced dyskinesias in Parkinson's disease: High striatal serotonin/dopamine transporter ratio |
| 001719 (2011) |
Morvarid Karimi [États-Unis] ; Stephen M. Moerlein [États-Unis] ; Tom O. Videen [États-Unis] ; Robert R. Luedtke [États-Unis] ; Michelle Taylor [États-Unis] ; Robert H. Mach [États-Unis] ; Joel S. Perlmutter [États-Unis] | Decreased striatal dopamine receptor binding in primary focal dystonia: A D2 or D3 defect? |
| 002344 (2009) |
Wassilios Meissner [France] ; Frédéric Macia [France] ; Alexandra Foubert-Samier [France] ; Martine Guyot [France] ; Emmanuel Bussy [France] ; Michèle Allard [France] ; François Tison [France] | Dopamine transporter binding is reduced following disulfiram‐induced striatal damage |
| 002416 (2009) |
Frank Andersohn [Allemagne] ; Edeltraut Garbe [Allemagne] | Cardiac and noncardiac fibrotic reactions caused by ergot‐and nonergot‐derived dopamine agonists |
| 002622 (2008) |
Irena Rektorova [République tchèque] ; Hana Srovnalova [République tchèque] ; Radka Kubikova [République tchèque] ; Jiri Prasek [République tchèque] | Striatal dopamine transporter imaging correlates with depressive symptoms and tower of London task performance in Parkinson's disease |
| 003125 (2006) |
Ji-Youn Kim [Corée du Sud] ; Eun Joo Chung [Corée du Sud] ; Seung Woo Park [Corée du Sud] ; Won Yong Lee [Corée du Sud] | Valvular heart disease in Parkinson's disease treated with ergot derivative dopamine agonists |
| 003177 (2006) |
Ioannis U. Isaias [Italie] ; Riccardo Benti [Italie] ; Stefano Goldwurm [Italie] ; Michela Zini [Italie] ; Roberto Cilia [Italie] ; Paolo Gerundini [Italie] ; Alessio Di Fonzo [Pays-Bas, Italie] ; Vincenzo Bonifati [Pays-Bas, Italie] ; Gianni Pezzoli [Italie] ; Angelo Antonini [Italie] | Striatal dopamine transporter binding in Parkinson's disease associated with the LRRK2 Gly2019Ser mutation |
| 003185 (2006) |
Matthias Reimold [Allemagne] ; Christoph Globas [Allemagne] ; Marc Gleichmann [Allemagne] ; Michael Schulze [Allemagne] ; Christian Gerloff [Allemagne] ; Roland Bares [Allemagne] ; H. Machulla [Allemagne] ; Katrin Bürk [Allemagne] | Spinocerebellar ataxia type 1, 2, and 3 and restless legs syndrome: Striatal dopamine D2 receptor status investigated by [11C]raclopride positron emission tomography |
| 003A92 (2004) |
K. Ray Chaudhuri [Royaume-Uni] ; Vandena Dhawan [Royaume-Uni] ; Sumit Basu [Royaume-Uni] ; Gordon Jackson [Royaume-Uni] ; Per Odin [Allemagne] | Valvular heart disease and fibrotic reactions may be related to ergot dopamine agonists, but non‐ergot agonists may also not be spared |
| 003B13 (2004) |
Katherine Grosset [Royaume-Uni] ; Fiona Needleman [Royaume-Uni] ; Graeme Macphee [Royaume-Uni] ; Donald Grosset [Royaume-Uni] | Switching from ergot to nonergot dopamine agonists in Parkinson's disease: A clinical series and five‐drug dose conversion table |
| 003B32 (2004) |
Judit Horvath [Suisse] ; Robin D. Fross [États-Unis] ; Galit Kleiner-Fisman [Canada] ; René Lerch [Suisse] ; Hans Stalder [Suisse] ; Suzanne Liaudat [Suisse] ; William J. Raskoff [États-Unis] ; Keith D. Flachsbart [États-Unis] ; Harry Rakowski [Canada] ; Jean-Claude Pache [Suisse] ; Pierre R. Burkhard [Suisse] ; Anthony E. Lang [Canada] | Severe multivalvular heart disease: A new complication of the ergot derivative dopamine agonists |
| 003C40 (2004) |
Olivier Rascol [France] ; Atul Pathak [France] ; Haleh Bagheri [France] ; Jean-Louis Montastruc [France] | New concerns about old drugs: Valvular heart disease on ergot derivative dopamine agonists as an exemplary situation of pharmacovigilance |
| 003C63 (2004) |
Andrew H. Evans [Royaume-Uni] ; Durval C. Costa ; Sveto Gacinovic [Royaume-Uni] ; Regina Katzenschlager [Royaume-Uni] ; John D. O'Sullivan [Australie] ; Simon Heales [Royaume-Uni] ; Phillip Lee [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | L‐dopa–responsive Parkinson's syndrome in association with phenylketonuria: In vivo dopamine transporter and D2 receptor findings |
| 003E09 (2004) |
Sebastian Paus [Allemagne] ; Gert Seeger [Allemagne] ; Hans M. Brecht [Allemagne] ; Jürgen Köster [Allemagne] ; Mahha El-Faddagh [Allemagne] ; Markus M. Nöthen [Belgique] ; Thomas Klockgether [Allemagne] ; Ullrich Wüllner [Allemagne] | Association study of dopamine D2, D3, D4 receptor and serotonin transporter gene polymorphisms with sleep attacks in Parkinson's disease |
| 004138 (2003) |
Joong-Seok Kim [Corée du Sud] ; Kwang-Soo Lee [Corée du Sud] ; Si-Ryung Han [Corée du Sud] ; Yong-An Chung [Corée du Sud] | Decreased striatal dopamine transporter binding in a patient with extrapontine myelinolysis |
| 004532 (2002) |
Yun J. Kim [Canada] ; Masanori Ichise [Canada] ; James R. Ballinger [Canada] ; Douglas Vines [Canada] ; Sean S. Erami [Canada] ; Tatsuro Tatschida [Canada] ; Anthony E. Lang [Canada] | Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP |
| 004721 (2001) |
Marie-Paule Muriel [France] ; Yves Agid [France] ; Etienne Hirsch [France] | Plasticity of afferent fibers to striatal neurons bearing D1 dopamine receptors in Parkinson's disease |
| 004C27 (1999) |
J. Eric Ahlskog [États-Unis] ; Ryan J. Uitti [États-Unis] ; Michael K. O'Connor [États-Unis] ; Demetrius M. Maraganore [États-Unis] ; Joseph Y. Matsumoto [États-Unis] ; Kathy F. Stark [États-Unis] ; Margaret F. Turk [États-Unis] ; Omer L. Burnett [États-Unis] | The effect of dopamine agonist therapy on dopamine transporter imaging in Parkinson's disease |
| 004C34 (1999) |
Christine Dentresangle [France] ; Laurent Veyre [France] ; Didier Le Bars [France] ; Christian Pierre [France] ; Frank Lavenne [France] ; Pierre Pollak [France] ; Jeanine Guerin [France] ; Jean-Claude Froment [France] ; Emmanuel Brousolle [France] | Striatal D2 dopamine receptor status in Parkinson's disease: An [18F]dopa and [11C]Raclopride PET study |
| 004D56 (1999) |
Robert B. Innis ; Kenneth L. Marek ; Kim Sheff ; Sami Zoghbi ; Joseph Castronuovo [États-Unis] ; Andrew Feigin [États-Unis] ; John P. Seibyl | Effect of treatment with L‐dopa/carbidopa or L‐selegiline on striatal dopamine transporter SPECT imaging with [123I]β‐CIT |
| 005319 (1997) |
Angelo Antonini [Suisse] ; Johannes Schwarz [Suisse] ; Wolfgang H. Oertel [Suisse] ; Oliver Pogarell [Suisse] ; Leenders [Suisse, Allemagne] | Long‐term changes of striatal dopamine D2 Receptors in patients with Parkinson's disease: A study with positron emission tomography and [11C]Raclopride |
| 005B26 (1994) |
Belluzzi [États-Unis] ; E. F. Domino [États-Unis] ; J. M. May [États-Unis] ; K. S. Bankiewicz [États-Unis] ; D. A. Mcafee [États-Unis] | N‐0923, a selective dopamine D2 receptor agonist, is efficacious in rat and monkey models of Parkinson's disease |
| 005D54 (1993) |
Rinne [Finlande] ; A. Laihinen [Finlande] ; U. K. Rinne [Finlande] ; K. N Gren [Finlande] ; J. Bergman [Finlande] ; U. Ruotsalainen [Finlande] | PET study on striatal dopamine D2 receptor changes during the progression of early parkinson's disease |
| 005F93 (1992) |
Schwarz [Allemagne] ; K. Tatsch [Allemagne] ; T. Vogl [Allemagne] ; C. M. Kirsch [Allemagne] ; C. Trenkwalder [Allemagne] ; G. Arnold [Allemagne] ; T. Gasser [Allemagne] ; W. H. Oertel [Allemagne] | Marked reduction of striatal dopamine D2 receptors as detected by 123IBZM‐SPECT in a Wilson's disease patient with generalized dystonia |
| 006341 (1990) |
Poewe [Autriche] ; G. Luef [Autriche] ; B. Kleedorfer [Autriche] ; M. Emre [Suisse] | Antiparkinsonian activity of a non‐ergot dopamine agonist, CV 205‐502, in patients with fluctuating Parkinson's disease |
| 006392 (1990) |
Werner Poewe [Autriche] ; G. Luef ; B. Kleedorfer ; M. Emre | Antiparkinsonian activity of a non-ergot dopamine agonist, CV 205-502, in patients with fluctuating Parkinson's disease |
| 006476 (1989) |
J. A. Temlett [Suisse] ; N. P. Quinn [Royaume-Uni] ; P. G. Jenner [Suisse] ; C. D. Marsden [Royaume-Uni] ; E. Pourcher [France] ; A. Bonnet [France] ; Yves Agid [France] ; R. Markstein [Suisse] ; X. Lataste [Suisse] | Antiparkinsonian activity of CY 208–243, a partial D‐1 dopamine receptor agonist, in MPTP‐treated marmosets and patients with Parkinson's disease |
| 000001 (2015) |
Danhui Zhang [États-Unis] ; Matthew Mcgregor [États-Unis] ; Tanuja Bordia [États-Unis] ; Xiomara A. Perez [États-Unis] ; J Michael Mcintosh [États-Unis] ; Michael W. Decker [États-Unis] ; Maryka Quik [États-Unis] | α7 nicotinic receptor agonists reduce levodopa-induced dyskinesias with severe nigrostriatal damage. |
| 000002 (2015) |
Doris E. Payer [Canada] ; Mark Guttman ; Stephen J. Kish ; Junchao Tong ; Antonio Strafella ; Martin Zack ; John R. Adams ; Pablo Rusjan ; Sylvain Houle ; Yoshiaki Furukawa ; Alan A. Wilson ; Isabelle Boileau | [¹¹C]-(+)-PHNO PET imaging of dopamine D(2/3) receptors in Parkinson's disease with impulse control disorders. |
| 000054 (2015) |
Paolo Solla [Italie] ; Alfonso Fasano [Canada] ; Antonino Cannas [Italie] ; Francesco Marrosu [Italie] | Suicide and dopamine agonist withdrawal syndrome in Parkinson's disease. |
| 000057 (2015) |
Carole Carcenac [France] ; Mathieu Favier ; Yvan Vachez ; Emilie Lacombe ; Sébastien Carnicella ; Marc Savasta ; Sabrina Boulet | Subthalamic deep brain stimulation differently alters striatal dopaminergic receptor levels in rats. |
| 000186 (2015) |
Françoise J. Siepel [Norvège] ; Ingvild Dalen [Norvège] ; Renate Grüner [Norvège] ; Jan Booij [Pays-Bas] ; Kolbj Rn S. Br Nnick [Norvège] ; Tirza C. Buter [Norvège] ; Dag Aarsland [Norvège] | Loss of Dopamine Transporter Binding and Clinical Symptoms in Dementia With Lewy Bodies. |
| 000313 (2015) |
Maxime Cazorla [États-Unis] ; Un Jung Kang [États-Unis] ; Christoph Kellendonk [États-Unis] | Balancing the basal ganglia circuitry: a possible new role for dopamine D2 receptors in health and disease. |
| 000365 (2014) |
Shiguo Liu [République populaire de Chine] ; Jiajia Cui ; Xinhua Zhang ; Weifeng Wu ; Haitao Niu ; Xu Ma ; Hongmei Xu ; Mingji Yi | Variable number tandem repeats in dopamine receptor D4 in Tourette's syndrome. |
| 000369 (2014) |
Souha Mahmoudi [Canada] ; Daniel Lévesque ; Pierre J. Blanchet | Upregulation of dopamine D3, not D2, receptors correlates with tardive dyskinesia in a primate model. |
| 000428 (2014) |
Roberto Cilia [Italie] ; Giorgio Marotta ; Alice Belletti ; Chiara Siri ; Gianni Pezzoli | Reversible dopamine transporter reduction in drug-induced Parkinsonism. |
| 000446 (2014) |
Chris Vriend [Pays-Bas] ; Anna H. Nordbeck ; Jan Booij ; Ysbrand D. Van Der Werf ; Tommy Pattij ; Pieter Voorn ; Pieter Raijmakers ; Elisabeth M J. Foncke ; Elsmarieke Van De Giessen ; Henk W. Berendse ; Odile A. Van Den Heuvel | Reduced dopamine transporter binding predates impulse control disorders in Parkinson's disease. |
| 000453 (2014) |
Robert A. Hauser [États-Unis] ; Dee Silver ; Azhar Choudhry ; Eli Eyal ; Stuart Isaacson | Randomized, controlled trial of rasagiline as an add-on to dopamine agonists in Parkinson's disease. |
| 000561 (2014) |
Shekeeb S. Mohammad [Australie] ; Kate Sinclair ; Sekhar Pillai ; Vera Merheb ; Tim D. Aumann ; Deepak Gill ; Russell C. Dale ; Fabienne Brilot | Herpes simplex encephalitis relapse with chorea is associated with autoantibodies to N-Methyl-D-aspartate receptor or dopamine-2 receptor. |
| 000688 (2014) |
Peter Jenner [Royaume-Uni] | A late appearance by the dopamine D-3 receptor. |
| 000705 (2013) |
Stefanie Reyes [Australie] ; Veronica Cottam ; Deniz Kirik ; Kay L. Double ; Glenda M. Halliday | Variability in neuronal expression of dopamine receptors and transporters in the substantia nigra. |
| 000775 (2013) |
Chun-Hui Chang [États-Unis] ; Anthony A. Grace | Some dopamine neurons may be more impulsive than others: why differences in receptors and transporters can affect dopamine function in Parkinson's disease. |
| 000796 (2013) |
Michele Poletti ; Ubaldo Bonuccelli | Reply: dopamine agonists and delusional jealousy in Parkinson's disease: a cross-sectional prevalence study. |
| 000808 (2013) |
Bettina Balint [Allemagne] ; Kailash Bhatia | Reopening the case for anti-basal ganglia antibodies (ABGAs): identification of dopamine-2 receptor antibodies associated with movement disorders. |
| 000971 (2013) |
Uriel Heresco-Levy [Israël] ; Shai Shoham ; Daniel C. Javitt | Glycine site agonists of the N-methyl-D-aspartate receptor and Parkinson's disease: a hypothesis. |
| 000A22 (2013) |
Maria Stamelou ; Christos Christodoulou ; Leonidas Stefanis | Dopamine agonists and delusional jealousy in Parkinson's disease: a cross-sectional prevalence study. |
| 000A70 (2013) |
Ledia F. Hernandez [Espagne] | Cholinergic neurons: an unexpected source of striatal dopamine release. |
| 000D33 (2012) |
Michele Morari [Italie] | L-dopa impairs proteasome activity in Parkinsonism through D1 dopamine receptor. |
| 000E06 (2012) |
Bernard Ravina [États-Unis] ; Kenneth Marek ; Shirley Eberly ; David Oakes ; Roger Kurlan ; Alberto Ascherio ; Flint Beal ; James Beck ; Emily Flagg ; Wendy R. Galpern ; Jennifer Harman ; Anthony E. Lang ; Michael Schwarzschild ; Caroline Tanner ; Ira Shoulson | Dopamine transporter imaging is associated with long-term outcomes in Parkinson's disease. |
| 000E07 (2012) |
Laura D. Perju-Dumbrava [Autriche] ; Gabor G. Kovacs ; Susanne Pirker ; Kurt Jellinger ; Martha Hoffmann ; Susanne Asenbaum ; Walter Pirker | Dopamine transporter imaging in autopsy-confirmed Parkinson's disease and multiple system atrophy. |
| 000E09 (2012) |
Michele Poletti [Italie] ; Giulio Perugi ; Chiara Logi ; Anna Romano ; Paolo Del Dotto ; Roberto Ceravolo ; Giuseppe Rossi ; Pasquale Pepe ; Liliana Dell'Osso ; Ubaldo Bonuccelli | Dopamine agonists and delusional jealousy in Parkinson's disease: a cross-sectional prevalence study. |
| 001139 (2012) |
Laura D. Perju-Dumbrava [Autriche] ; Gabor G. Kovacs [Autriche] ; Susanne Pirker [Autriche] ; Kurt Jellinger [Autriche] ; Martha Hoffmann [Autriche] ; Susanne Asenbaum [Autriche] ; Walter Pirker [Autriche] | Dopamine Transporter Imaging in Autopsy-Confirmed Parkinson's Disease and Multiple System Atrophy |
| 001140 (2012) |
Bernard Ravina [États-Unis] ; Kenneth Marek [États-Unis] ; Shirley Eberly [États-Unis] ; David Oakes [États-Unis] ; Roger Kurlan [États-Unis] ; Alberto Ascherio [États-Unis] ; Flint Beal [États-Unis] ; James Beck [États-Unis] ; Emily Flagg [États-Unis] ; Wendy R. Galpern [États-Unis] ; Jennifer Harman [États-Unis] ; Anthony E. Lang [Canada] ; Michael Schwarzschild [États-Unis] ; Caroline Tanner [États-Unis] ; Ira Shoulson [États-Unis] | Dopamine Transporter Imaging Is Associated With Long-Term Outcomes in Parkinson's Disease |
| 001141 (2012) |
Michele Poletti [Italie] ; Giulio Perugi [Italie] ; Chiara Logi [Italie] ; Anna Romano [Italie] ; Paolo Del Dotto [Italie] ; Roberto Ceravolo [Italie] ; Giuseppe Rossi [Italie] ; Pasquale Pepe [Italie] ; Liliana Dell'Osso [Italie] ; Ubaldo Bonuccelli [Italie] | Dopamine Agonists and Delusional Jealousy in Parkinson's Disease: A Cross-Sectional Prevalence Study |
| 001376 (2011) |
| Striatal synaptic plasticity following various degrees of dopamine denervation |
| 001772 (2011) |
Dario Benincasa [Italie] ; Clelia Pellicano [Italie] ; Alessandra Fanciulli [Italie] ; Francesco E. Pontieri [Italie] | Bupropion abates dopamine agonist‐mediated compulsive behaviors in Parkinson's disease |
| 001C03 (2010) |
Fanny Pineau [France] ; Michael Schüpbach [France] ; Jean-Christophe Corvol [France] ; Constance Flamand-Rouvière [France] ; Marie Vidailhet [France] ; Emmanuel Roze [France] | Long‐standing paraphilia induced by dopamine agonists in Parkinson's disease |
| 001C55 (2010) |
Mario Coletti Moja [Italie] | Hiccups associated with non‐ergoline dopamine agonists in Parkinson's disease |
| 001C97 (2010) |
Marta G. Vu Ckovi [États-Unis] ; Quanzheng Li [États-Unis] ; Beth Fisher [États-Unis] ; Angelo Nacca [États-Unis] ; Richard M. Leahy [États-Unis] ; John P. Walsh [États-Unis] ; Jogesh Mukherjee [États-Unis] ; Celia Williams [États-Unis] ; Michael W. Jakowec [États-Unis] ; Giselle M. Petzinger [États-Unis] | Exercise elevates dopamine D2 receptor in a mouse model of Parkinson's disease: In vivo imaging with [18F]fallypride |
| 001D33 (2010) |
Juliana Bronzova [Pays-Bas] ; Cristina Sampaio [Portugal] ; Robert A. Hauser [États-Unis] ; Anthony E. Lang [Canada] ; Olivier Rascol [France] ; Ad Theeuwes [Pays-Bas] ; Serge V. Van De Witte [Pays-Bas] ; Guus Van Scharrenburg [Pays-Bas] | Double‐blind study of pardoprunox, a new partial dopamine agonist, in early Parkinson's disease |
| 001E61 (2010) |
Santiago Perez-Lloret [France] ; Emmanuelle Bondon-Guitton [France] ; Olivier Rascol [France] ; Jean-Louis Montastruc [France] | Adverse drug reactions to dopamine agonists: A comparative study in the french pharmacovigilance database |
| 001F53 (2010) |
Marta G. Vuckovic [États-Unis] ; QUANZHENG LI [États-Unis] ; Beth Fisher [États-Unis] ; Angelo Nacca [États-Unis] ; Richard M. Leahy [États-Unis] ; John P. Walsh [États-Unis] ; Jogesh Mukherjee [États-Unis] ; Celia Williams [États-Unis] ; Michael W. Jakowec [États-Unis] ; Giselle M. Petzinger [États-Unis] | Exercise Elevates Dopamine D2 Receptor in a Mouse Model of Parkinson's Disease: In Vivo Imaging with [18F]Fallypride |
| 001F72 (2010) |
Santiago Perez-Lloret [France] ; Emmanuelle Bondon-Guitton [France] ; Olivier Rascol [France] ; Jean-Louis Montastruc [France] | Adverse Drug Reactions to Dopamine Agonists: A Comparative Study in the French Pharmacovigilance Database |
| 002055 (2009) |
Francesco Roselli [Italie, Allemagne] ; Nicola M. Pisciotta [Italie] ; Robert Perneczky [Allemagne] ; Michele Pennelli [Italie] ; Maria S. Aniello [Italie] ; Maria F. De Caro [Italie] ; Ermanno Ferrannini [Italie] ; Bruno Tartaglione [Italie] ; Giovanni Defazio [Italie] ; Giuseppe Rubini [Italie] ; Paolo Livrea [Italie] | Severity of neuropsychiatric symptoms and dopamine transporter levels in dementia with Lewy bodies: A 123I‐FP‐CIT SPECT study |
| 002058 (2009) |
Nadeeka N. W. Dissanayaka [Australie] ; Peter A. Silburn [Australie] ; John D. O'Sullivan [Australie] ; George D. Mellick [Australie] | Serotonin and dopamine transporter genes do not influence depression in Parkinson's disease |
| 002092 (2009) |
Susanne A. Schneider [Royaume-Uni] ; Vrajesh Udani [Inde] ; Charulata Sawant Sankhla [Inde] ; Kailash P. Bhatia [Royaume-Uni] | Recurrent acute dystonic reaction and oculogyric crisis despite withdrawal of dopamine receptor blocking drugs |
| 002107 (2009) |
Andrew H. Evans [Australie] ; James R. Stegeman [Australie] | Punding in patients on dopamine agonists for restless leg syndrome |
| 002343 (2009) |
Rodney W. H. Walker [Royaume-Uni] ; Zuzana Walker [Royaume-Uni] | Dopamine transporter single photon emission computerized tomography in the diagnosis of dementia with Lewy bodies |
| 002345 (2009) |
Christoph Scherfler [Autriche] ; Michael Nocker [Autriche] | Dopamine transporter SPECT: How to remove subjectivity? |
| 002346 (2009) |
Elena García-Martín [Espagne] ; Carmen Martínez [Espagne] ; Hortensia Alonso-Navarro [Espagne] ; Julián Benito-Le N [Espagne] ; Inmaculada Puertas [Espagne] ; Lluisa Rubio [Espagne] ; Tomás L Pez-Alburquerque [Espagne] ; José A. G. Agúndez [Espagne] ; Félix Javier Jiménez-Jiménez [Espagne] | Dopamine receptor D3 (DRD3) genotype and allelic variants and risk for essential tremor |
| 002348 (2009) |
Akiyuki Uzawa [Japon] ; Masahiro Mori [Japon] ; Shigeyuki Kojima [Japon] ; Satsuki Mitsuma [Japon] ; Yukari Sekiguchi [Japon] ; Toshihide Kanesaka [Japon] ; Satoshi Kuwabara [Japon] | Dopamine agonist‐induced antecollis in Parkinson's disease |
| 002349 (2009) |
Vincenzo Rizzo [Italie] ; Irene Aric [Italie] ; Claudia Mastroeni [Italie] ; Francesca Morgante [Italie] ; Giovanna Liotta [Italie] ; Paolo Girlanda [Italie] ; Rosalia Silvestri [Italie] ; Angelo Quartarone [Italie] | Dopamine agonists restore cortical plasticity in patients with idiopathic restless legs syndrome |
| 002521 (2009) |
Elena Garcia-Martin [Espagne] ; Carmen Martinez [Espagne] ; Hortensia Alonso-Navarro [Espagne] ; Julián Benito-Leon [Espagne] ; Inmaculada Puertas [Espagne] ; Lluisa Rubio [Espagne] ; Tomás Lopez-Alburquerque [Espagne] ; José A. G. Agundez [Espagne] ; Félix Javier Jimenez-Jimenez [Espagne] | Dopamine Receptor D3 (DRD3) Genotype and Allelic Variants and Risk for Essential Tremor |
| 002623 (2008) |
Yoland Smith [États-Unis] ; Rosa Villalba [États-Unis] | Striatal and extrastriatal dopamine in the basal ganglia: An overview of its anatomical organization in normal and Parkinsonian brains |
| 002729 (2008) |
Sean S. O'Sullivan [Royaume-Uni] ; David J. Burn [Royaume-Uni] ; Janice L. Holton [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Normal dopamine transporter single photon‐emission CT scan in corticobasal degeneration |
| 002732 (2008) |
Gabor G. Kovacs [Autriche] ; Ivan J. Milenkovic [Autriche] ; Matthias Preusser [Autriche] ; Herbert Budka [Autriche] | Nigral burden of α‐synuclein correlates with striatal dopamine deficit |
| 002B03 (2007) |
Susann Junghanns [Allemagne] ; Joerg T. Fuhrmann [Allemagne] ; Gregor Simonis [Allemagne] ; Christian Oelwein [Allemagne] ; Rainer Koch [Allemagne] ; Ruth H. Strasser [Allemagne] ; Heinz Reichmann [Allemagne] ; Alexander Storch [Allemagne] | Valvular heart disease in Parkinson's disease patients treated with dopamine agonists: A reader‐blinded monocenter echocardiography study |
| 002B58 (2007) |
Penelope J. Hallett [États-Unis] ; J. M. Brotchie [Canada] | Striatal delta opioid receptor binding in experimental models of Parkinson's disease and dyskinesia |
| 002C01 (2007) |
Kumar M. Prakash ; Anthony E. Lang | Reversible dopamine agonist induced anterocollis in a multiple system atrophy patient |
| 002D48 (2007) |
Gregor Simonis [Allemagne] ; Joerg T. Fuhrmann [Allemagne] ; Ruth H. Strasser [Allemagne] | Meta‐analysis of heart valve abnormalities in Parkinson's disease patients treated with dopamine agonists |
| 002E18 (2007) |
Jacobo Lester [Mexique] ; Gabriela Beatriz Raina [Argentine] ; Claudia Uribe-Roca [Argentine] ; Federico Micheli [Argentine] | Hiccup secondary to dopamine agonists in Parkinson's Disease |
| 002E87 (2007) |
Andrew H. Evans [Australie] ; Helmut Butzkueven [Australie] | Dopamine agonist‐induced pathological gambling in restless legs syndrome due to multiple sclerosis |
| 003030 (2007) |
Kjell Fuxe [Suède] ; Daniel Marcellino [Suède] ; Susanna Genedani [Italie] ; Luigi Agnati [Italie] | Adenosine A2A receptors, dopamine D2 receptors and their interactions in Parkinson's disease |
| 003131 (2006) |
Christoph Scherfler [Royaume-Uni] ; Naheed L. Khan [Royaume-Uni] ; Nicola Pavese [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Niall P. Quinn [Royaume-Uni] ; David J. Brooks [Royaume-Uni] ; Paola P. Piccini [Royaume-Uni] | Upregulation of dopamine D2 receptors in dopaminergic drug‐naive patients with parkin gene mutations |
| 003243 (2006) |
Katherine A. Grosset [Royaume-Uni] ; Graeme Macphee [Royaume-Uni] ; Guru Pal [Royaume-Uni] ; David Stewart [Royaume-Uni] ; Andrew Watt [Royaume-Uni] ; Jim Davie [Royaume-Uni] ; D. G. Grosset [Royaume-Uni] | Problematic gambling on dopamine agonists: Not such a rarity |
| 003402 (2006) |
Jordi Gomez-Ramirez [Canada] ; Tom H. Johnston [Canada] ; Naomi P. Visanji [Canada] ; Susan H. Fox [Canada] ; Jonathan M. Brotchie [Canada] | Histamine H3 receptor agonists reduce L‐dopa–induced chorea, but not dystonia, in the MPTP‐lesioned nonhuman primate model of Parkinson's disease |
| 003463 (2006) |
Daniel Oved [Israël] ; Ilan Ziv [Israël] ; Therese A. Treves [Israël] ; Diana Paleacu [Israël] ; Eldad Melamed [Israël] ; Ruth Djaldetti [Israël] | Effect of dopamine agonists on fatigue and somnolence in Parkinson's disease |
| 003477 (2006) |
Stefanie Klaffke [Allemagne] ; Andrea A. Kuhn [Allemagne] ; Michail Plotkin [Allemagne] ; Holger Amthauer [Allemagne] ; Daniel Harnack [Allemagne] ; Roland Felix [Allemagne] ; Andreas Kupsch [Allemagne] | Dopamine transporters, D2 receptors, and glucose metabolism in corticobasal degeneration |
| 003518 (2006) |
Melissa J. Nirenberg [États-Unis] ; Cheryl Waters [États-Unis] | Compulsive eating and weight gain related to dopamine agonist use |
| 003652 (2006) |
Jordi Gomez-Ramirez [Canada] ; Tom H. Johnston [Canada] ; Naomi P. Visanji [Canada] ; Susan H. Fox [Canada] ; Jonathan M. Brotchie [Canada] | Histamine H3 receptor agonists reduce L-dopa-induced chorea, but not dystonia, in the MPTP-lesioned nonhuman primate model of parkinson's disease |
| 003742 (2005) |
Katherine L. Widnell [États-Unis] ; Cynthia Comella [États-Unis] | Role of COMT inhibitors and dopamine agonists in the treatment of motor fluctuations |
| 003C21 (2004) |
Karin Stiasny-Kolster [Allemagne] ; Ralf Kohnen [Allemagne] ; Erwin Schollmayer [Allemagne] ; J. Carsten Möller [Allemagne] ; Wolfgang H. Oertel [Allemagne] | Patch application of the dopamine agonist rotigotine to patients with moderate to advanced stages of restless legs syndrome: A double‐blind, placebo‐controlled pilot study |
| 003C79 (2004) |
Valtteri Kaasinen [Finlande] ; Sargo Aalto [Finlande] ; Kjell N Gren [Finlande] ; Juha O. Rinne [Finlande] | Insular dopamine D2 receptors and novelty seeking personality in Parkinson's disease |
